In terms of quality of life, someone 75 years old, retired with significant memory problems, can still have friends and, “a ...

As pharmaceutical companies struggle to develop Alzheimer’s treatments, scientists are searching for existing drugs that ...

Okanagan Clinical Trials is offering new opportunities for people to participate in important clinical research studies ...

The European Medicines Agency (EMA) cleared the way for the use of another drug to treat Alzheimer's disease on Friday.

Individuals treated for breast cancer often develop cognitive issues, but they may have a lower risk for developing Alzheimer ...

The combination of a recently approved blood test for detection of Alzheimer's disease combined with two medications that ...

Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.

The AFA opens a new Alzheimer’s support center in Amityville, offering programs, memory screenings and caregiver respite for ...

Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...

Without the receptor, ADGRG1, the microglia barely nibbled on the toxic protein. Using a mouse model of Alzheimer’s disease, the researchers observed how the loss of ADGRG1 led to the rapid buildup of ...

Li, Huang, and Sirota chose 2 cancer drugs out of the top 5 drug candidates for laboratory testing. They predicted one drug, ...